Abstract
Low-dose combined oral contraceptives (COCs) can interfere with bone mass acquisition during adolescence. Objectives: This study aimed to evaluate bone mineral density (BMD), bone mineral content (BMC) and bone biomarkers in female adolescents taking a standard low-dose COC (ethinylestradiol 20 µg/desogestrel 150 µg) over a 1-year period and to compare their data with those of healthy ado…